A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. (Q36610713)
Jump to navigation
Jump to search
scientific article published on 27 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. |
scientific article published on 27 November 2007 |
Statements
1 reference
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. (English)
1 reference
S Steinbild
1 reference
K Mross
1 reference
A Frost
1 reference
R Morant
1 reference
C Dittrich
1 reference
A-R Hanauske
1 reference
L Edler
1 reference
I Burkholder
1 reference
M Scheulen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
2 references
1 reference
Identifiers
1 reference